(Q72938767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Treatment of cytomegalovirus pneumonia with high-dose acyclovir (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

Cytomegalovirus pneumonia

1 reference

1 reference

J. C. Wade

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

M. Hintz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

R. McGuffin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

S. C. Springmeyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

J. D. Connor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

J. D. Meyers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285716

16 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6285716

16 September 2023

publication date

1 July 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

20 July 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6285716

full work available at URL

16 September 2023

https://api.elsevier.com/content/article/PII:0002934382901000?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

https://api.elsevier.com/content/article/PII:0002934382901000?httpAccept=text/plain

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

American Journal of Medicine

16 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

249-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

Prophylactic adenine arabinoside following marrow transplantation

30 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow Transplantation

16 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon

16 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Acyclovir prophylaxis of herpes-simplex-virus infections

16 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients

16 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections

16 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

16 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Parenteral acyclovir therapy for herpesvirus infections in man

16 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

16 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

16 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

16 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses

16 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro

16 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Bone-marrow transplantation (first of two parts).

16 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Bone-marrow transplantation (second of two parts).

16 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Seroepidemiology of infectious due to members of the herpesvirus group

16 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]

16 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow Transplant

16 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir

16 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Cytomegalovirus: Clinical virological correlations in renal transplant recipients

16 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution

16 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90100-0

16 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285716%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference